VestGen Advisors’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
VestGen Advisors's HAE Position: Q3 2026 in Review
VestGen Advisors opened a new position in Haemonetics (HAE) in Q3 2026: 27,550 shares worth $2.9M. The stake represents 0.09% of the portfolio and ranks #210 among its holdings.
361 funds tracked by Wall St. Rank hold HAE as of Q3 2026.
- VestGen Advisors held 27,550 shares of Haemonetics worth $2.9M as of Q3 2026.
- Haemonetics was a new VestGen Advisors position in Q3 2026.
- Haemonetics made up 0.09% of VestGen Advisors's portfolio in Q3 2026, its #210 holding.
- 361 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.
Based on VestGen Advisors's 13F filing for Q3 2026, filed 27 Oct 2026.